Award
National Cancer Institute 5R21CA282857-02
Discovery and anti-tumor activity of the first antagonists targeting human Sonic Hedgehog autoprocessing
Recipient
Binghamton
Award Amount
$219,881.00
Ceiling
$219,881.00
Awarded
February 13, 2025
Identifier
5R21CA282857-02
Award for research on discovering and evaluating small molecule antagonists targeting human Sonic Hedgehog autoprocessing for anti-cancer therapy, funded by NIH/NCI.
Description
This project involves the discovery and evaluation of small molecules targeting human Sonic Hedgehog autoprocessing, with potential anti-cancer therapeutic applications. The project includes high throughput screening and preclinical evaluation, funded by the NIH/NCI.